A previous clinical trial found that tamoxifen, taken for five years, reduced the risk of developing invasive breast cancer by about 50% in post-menopausal women who were at increased risk of getting the disease.
Another trial found that five years of raloxifene reduces breast cancer risk in such women by about 38%.
Under the new plans, high risk post-menopausal women could be offered the drugs for a period of five years unless they have a history of thromboembolic disease or endometrial cancer.
More top news
Singer reaches settlement with police following legal fight prompted by investigation conducted into him following sex assault allegations.
Manchester musicians Liam Gallagher, The Charlatans and Dave Haslam have pledged their support along with the Salford Red Devils.
Damon Smith from Newton Abbot was found guilty of planting a home-made bomb on the London Underground in October.